QIAGEN runs in vitro diagnostic (IVD) studies in busy clinical labs. It needed an EDC built for diagnostics, not pharma, that its own experts could build.
After evaluating six or seven providers, QIAGEN chose Medrio EDC to keep costs in line and study builds in-house.
In this downloadable case study, see how QIAGEN uses Medrio to achieve:
- Predictable, right-sized trial costs
- Faster data capture with lab-ready forms
- Hands-on support and partnership
| Contributing experts at QIAGEN include: Dr. Sarah Johnson, VP Head of Clinical Affairs Bouchra Dufour, PhD, Lead Senior Manager, Data Management |